Transient Global Ischemia Model
Objective: To determine whether caspase-3 serves to regulate neuronal death after cerebral ischemia and study the effect of caspase-3 inhibition on cell survival and DNA fragmentation in the hippocampus
This is a Transient Global Ischemia Model protocol using rat as the model organism. The procedure involves 6 procedural steps, 4 equipment items, 1 materials. Extracted from a 1998 paper published in Journal of Neuroscience.
Model and subjects
rat • Not specified • unknown • Not specified • Not specified
Study window
~1 week study window
Core workflow
Induction of transient global cerebral ischemia • Examination of caspase-3 mRNA expression • Examination of caspase-3 protein expression
Primary readouts
- caspase-3 mRNA expression levels
- caspase-3 protein expression levels
- caspase-3-like protease activity in brain cell extracts
- DNA fragmentation in neurons
Key equipment and reagents
Use this page as an execution guide, then fall back to the source paper whenever you need exact exclusions, dosing details, or assay-specific caveats.
Confirm first
- Verify the animal model, intervention setup, and collection timepoints against the source paper.
- Check that every direct vendor link matches the exact specification your lab plans to run.
Use the page like this
- Work through the protocol steps in order and use the inline vendor chips only when you need to source or verify an item.
- Jump to Experimental Context for readouts, data shape, and analysis flow before planning downstream analysis.
Protocol Steps
Start here. The step list is optimized for running the experiment, with direct vendor links available inline when you need to source a cited item.
Induction of transient global cerebral ischemia
Transient global cerebral ischemia was induced in rats using an unspecified method
Note: The specific ischemia induction method is not detailed in the provided text
View evidence from paper
“studied the effect of caspase-3 inhibition on cell survival and DNA fragmentation in the hippocampus in a rat model of transient global ischemia”
Examination of caspase-3 mRNA expression
caspase-3 mRNA expression in the brain was examined using in situ hybridization, Northern blot analyses
Note: Analysis performed at multiple timepoints post-ischemia
View evidence from paper
“At 8–72 hr after ischemia, caspase-3 mRNA and protein were induced in the hippocampus and caudate-putamen”
Examination of caspase-3 protein expression
caspase-3 protein expression in the brain was examined using Western blot analyses and double-labeled immunohistochemistry
Note: Protein predominantly increased in degenerating CA1 pyramidal neurons
View evidence from paper
“In the hippocampus, caspase-3 mRNA and protein were predominantly increased in degenerating CA1 pyramidal neurons”
Determination of caspase-3-like activity
Caspase-3-like activity was determined in brain cell extracts
Note: Proteolytic activation of caspase-3 precursor detected in hippocampus and caudate-putamen but not in cortex
View evidence from paper
“determined caspase-3-like activity in brain cell extracts; Proteolytic activation of the caspase-3 precursor was detected in hippocampus and CPu but not in cortex at 4–72 hr after ischemia”
Detection of DNA fragmentation
Double-label experiments were performed to detect DNA fragmentation in neurons overexpressing caspase-3
Note: DNA fragmentation detected in majority of CA1 neurons and selective caudate-putamen neurons
View evidence from paper
“Double-label experiments detected DNA fragmentation in the majority of CA1 neurons and selective CPu neurons that overexpressed caspase-3”
Ventricular infusion of caspase-3 inhibitor
Z-DEVD-FMK, a caspase-3 inhibitor, was administered via ventricular infusion to inhibit caspase-3 activity
Note: Inhibitor significantly reduced cell death and DNA fragmentation in CA1 sector
View evidence from paper
“ventricular infusion of Z-DEVD-FMK, a caspase-3 inhibitor, decreased caspase-3 activity in the hippocampus and significantly reduced cell death and DNA fragmentation in the CA1 sector up to 7 d after ischemia”